| 000 | 00979 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514012117.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0040-6376 | ||
| 024 | 7 |
_a10.1136/thorax.56.10.819b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmyth, A | |
| 245 | 0 | 0 |
_aCF and antistaphylococcal prophylaxis. _h[electronic resource] |
| 260 |
_bThorax _cOct 2001 |
||
| 300 |
_a819-20 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aCephalexin _xtherapeutic use |
| 650 | 0 | 4 |
_aCephalosporins _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aPseudomonas Infections _xcomplications |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xprevention & control |
| 700 | 1 | _aWalters, S | |
| 773 | 0 |
_tThorax _gvol. 56 _gno. 10 _gp. 819-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/thorax.56.10.819b _zAvailable from publisher's website |
| 999 |
_c11516577 _d11516577 |
||